CNTB
Connect Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CNTB Filings
Filing Date
Form Description
Form Type
2025-11-28
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-28 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-26
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-26 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-24
Form 144 - Report of proposed sale of securities
Ownership
2025-11-24 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-21
Form 144 - Report of proposed sale of securities
Ownership
2025-11-21 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-18
Form 144 - Report of proposed sale of securities
Ownership
2025-11-18 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-10-01
Form 144 - Report of proposed sale of securities
Ownership
2025-10-01 · Ownership
Form 144 - Report of proposed sale of securities
2025-09-16
Form 8-K - Current report
Key Events
2025-09-16 · Key Events
Form 8-K - Current report
2025-09-15
Form EFFECT - Notice of Effectiveness
2025-09-15 ·
Form EFFECT - Notice of Effectiveness
